mounjaro glp 1 agonist New Blockbuster Type 2 Medication Gets FDA Approval Can Mounjaro cause hair loss?

Asbestos trust funds were established in the 1970s to compensate workers harmed by asbestos-containing products

A five-month treatment with PEGylated exenatide (NLY01) was found to decrease the secretion of complement 1q (C1q), IL-1, and TNF- by primary mouse microglia, thereby limiting the conversion of astrocytes to a neurotoxic phenotype

The two-year-old startup has now raised more than $4 million in venture funding

Bariatric surgery patients also have improved health outcomes: a recent retrospective cohort study demonstrated that the incidence of extended major adverse cardiovascular events was 8% lower in patients with established cardiovascular disease who received bariatric surgery compared to their age, sex, and history matched control

The early success of these drugs in combating what was considered to be an intractable public health concern has begun to reshape how society is framing obesity as a health issue, leading to ripple effects that are affecting how food is sold and consumed, insurance and workplace wellness policies, and importantly, public attitudes surrounding the veracity of framing obesity as a medical issue that can and should be treated

[DOI] [PubMed] [Google Scholar] 9.Filippatos T, Milionis HJ